H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Medicine D-index 105 Citations 64,703 514 World Ranking 3011 National Ranking 133

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Disease
  • Alzheimer's disease

Dementia, Alzheimer's disease, Internal medicine, Psychiatry and Disease are his primary areas of study. The Dementia study combines topics in areas such as Cognition, Gerontology and Activities of daily living. His Alzheimer's disease research incorporates themes from Central nervous system disease, Neuroscience, Degenerative disease, Pediatrics and Cognitive disorder.

His studies in Internal medicine integrate themes in fields like Placebo, Irritability, Surgery and Endocrinology. His work deals with themes such as Memantine, Clinical trial and Clinical psychology, which intersect with Psychiatry. His Disease research also works with subjects such as

  • Intensive care medicine which intersects with area such as Florbetaben,
  • Cohort, which have a strong connection to Cohort study.

His most cited work include:

  • Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium (3883 citations)
  • Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria (3224 citations)
  • Mild cognitive impairment (2753 citations)

What are the main themes of his work throughout his whole career to date?

His main research concerns Disease, Dementia, Internal medicine, Alzheimer's disease and Psychiatry. His study looks at the relationship between Disease and topics such as Neuroscience, which overlap with Amyloid. His studies deal with areas such as Cognition, Gerontology and Clinical psychology as well as Dementia.

His Internal medicine study which covers Oncology that intersects with Biomarker. His research integrates issues of Central nervous system disease and Degenerative disease in his study of Alzheimer's disease. His research on Psychiatry frequently connects to adjacent areas such as MEDLINE.

He most often published in these fields:

  • Disease (37.70%)
  • Dementia (31.90%)
  • Internal medicine (25.47%)

What were the highlights of his more recent work (between 2018-2021)?

  • Disease (37.70%)
  • Dementia (31.90%)
  • Internal medicine (25.47%)

In recent papers he was focusing on the following fields of study:

Serge Gauthier mainly investigates Disease, Dementia, Internal medicine, Neuroimaging and Neuroscience. As part of one scientific family, Serge Gauthier deals mainly with the area of Disease, narrowing it down to issues related to the Cohort, and often Alzheimer's disease. Serge Gauthier studies Dementia, namely Cognitive decline.

The Internal medicine study which covers Magnetic resonance imaging that intersects with Cardiology. His Neuroimaging research is multidisciplinary, incorporating elements of Disease progression and Atrophy. His Neuroscience research incorporates elements of Neuroinflammation, Frontotemporal dementia and Disease spectrum.

Between 2018 and 2021, his most popular works were:

  • Dementia care during COVID-19 (191 citations)
  • Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts. (115 citations)
  • Dementia in China: epidemiology, clinical management, and research advances (75 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Disease
  • Alzheimer's disease

The scientist’s investigation covers issues in Dementia, Disease, Internal medicine, Cognition and Cognitive decline. His study in Dementia focuses on Frontotemporal dementia in particular. His study in Disease is interdisciplinary in nature, drawing from both Neurology, Cohort and Intensive care medicine.

His Cohort research includes themes of Alzheimer's disease, Mild memory loss, Population ageing and Gerontology. His Internal medicine study incorporates themes from Standardized uptake value, Magnetic resonance imaging and Oncology. Serge Gauthier interconnects Telemedicine, Telehealth, Applied psychology and Best practice in the investigation of issues within Cognition.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium

I. G. McKeith;I. G. McKeith;D. W. Dickson;J. Lowe;M. Emre.
Neurology (2005)

4931 Citations

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria

Bruno Dubois;Howard H. Feldman;Claudia Jacova;Steven T. DeKosky.
Lancet Neurology (2007)

4694 Citations

Mild cognitive impairment

Serge Gauthier;Barry Reisberg;Michael Zaudig;Ronald C. Petersen.
The Lancet (2006)

2753 Citations

Clinical diagnostic criteria for dementia associated with Parkinson's disease.

Murat Emre;Dag Aarsland;Dag Aarsland;Richard Brown;David J. Burn.
Movement Disorders (2007)

2449 Citations

Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria

Bruno Dubois;Bruno Dubois;Howard H Feldman;Claudia Jacova;Harald Hampel;Harald Hampel.
Lancet Neurology (2014)

2389 Citations

Revising the definition of Alzheimer's disease: a new lexicon.

Bruno Dubois;Howard H. Feldman;Howard H. Feldman;Howard H. Feldman;Claudia Jacova;Jeffrey L. Cummings.
Lancet Neurology (2010)

2082 Citations

Vascular Cognitive Impairment

John T O'Brien;Timo Erkinjuntti;Barry Reisberg;Gustavo Roman.
(2002)

1964 Citations

SeminarAlzheimer's disease

Clive Ballard;Serge Gauthier;Anne Corbett;Carol Brayne.
(2011)

1950 Citations

Prevalence and severity of cognitive impairment with and without dementia in an elderly population

Janice E Graham;Kenneth Rockwood;B Lynn Beattie;Robin Eastwood.
The Lancet (1997)

1357 Citations

Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial.

Michael Rösler;Ravi Anand;Ana Cicin-Sain;Serge Gauthier.
BMJ (1999)

1219 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Serge Gauthier

Kaj Blennow

Kaj Blennow

University of Gothenburg

Publications: 457

Henrik Zetterberg

Henrik Zetterberg

University of Gothenburg

Publications: 433

Dag Aarsland

Dag Aarsland

King's College London

Publications: 354

Philip Scheltens

Philip Scheltens

Vrije Universiteit Amsterdam

Publications: 287

Giovanni B. Frisoni

Giovanni B. Frisoni

University of Geneva

Publications: 243

Clive Ballard

Clive Ballard

University of Exeter

Publications: 227

Ronald C. Petersen

Ronald C. Petersen

Mayo Clinic

Publications: 225

John T. O'Brien

John T. O'Brien

University of Cambridge

Publications: 220

Bengt Winblad

Bengt Winblad

Karolinska Institute

Publications: 195

Harald Hampel

Harald Hampel

Université Paris Cité

Publications: 183

Bruno Vellas

Bruno Vellas

Federal University of Toulouse Midi-Pyrénées

Publications: 177

Jeffrey L. Cummings

Jeffrey L. Cummings

University of Nevada, Las Vegas

Publications: 174

Bruno Dubois

Bruno Dubois

Université Paris Cité

Publications: 170

Pieter Jelle Visser

Pieter Jelle Visser

Maastricht University

Publications: 167

Wiesje M. van der Flier

Wiesje M. van der Flier

Vrije Universiteit Amsterdam

Publications: 159

Oskar Hansson

Oskar Hansson

Lund University

Publications: 157

Something went wrong. Please try again later.